查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542974

全球生物列印器官移植市场 - 2024-2031

Global Bioprinting on Organ Transplant Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

器官移植市场的全球生物印刷在2023年达到10.5亿美元，预计到2031年将达到27.3亿美元，在2024-2031年预测期间复合年增长率为13.2%。

器官/组织的体外生物製造由两个需求驱动，即器官移植和精确的组织模型。生物列印，也称为三维 (3D) 列印，是一种用于开发许多组织/器官的技术，例如肝臟、皮肤和心臟。该技术与使用生物材料、活细胞和生物分子列印结构有关。生物人工器官的创造为未来的器官移植计画开闢了新的途径。

全球对器官移植的需求迅速增长。由于重要器官衰竭的发生率增加以及移植后结果的成功率较高，因此需要器官移植。在全球范围内，由于移植器官的需求增加和供应不足，出现了严重的器官短缺危机。 3D生物列印以细胞或其他生物材料为印刷油墨，根据仿生形态、生物功能和细胞微环境的要求，透过积层製造方法列印出具有生物功能的复杂3D生物结构。

市场动态：

司机

器官移植需求增加

全球器官移植市场对生物列印的需求是由多种因素所驱动的。人造器官和器官移植需求的增加推动了市场的成长。

此外，技术发展和研究工作资金分配将推动器官移植市场对全球生物列印的需求。例如，根据移植.hrsa.gov，2023 年有 46,632 例器官移植手术来自活体和已故捐赠者。例器官移植。已故捐赠者的器官移植数量为 39,679 例。这比 2022 年成长了 8.9%，也是连续第十一年创纪录。

例如，根据nih.gov 2024 年2 月发布的一篇文章，印度每年进行17,000-18,000 例实体器官移植，仅次于美国和中国，位居世界第一，但移植率仍落后于几个高收入国家每百万人口（0.65）。这一领域已经取得了进展，例如从已故捐赠者身上获取器官的情况有所改善，每个捐赠者的平均器官移植数量从 2016 年的 2.43 例增加到 2022 年的 3.05 例。

限制

器官移植相关的副作用和风险、人造器官的高成本、熟练专业人员的短缺以及新技术审批的严格监管要求等因素预计将阻碍市场。

细分市场分析

全球器官移植生物列印市场根据製程、生物墨水、使用的细胞类型、最终用户和地区进行细分。

基于挤压的生物列印领域约占全球器官移植生物列印市场份额的47.8%

基于挤出的生物列印领域预计将在预测期内占据最大的市场份额。在这一领域，政府监管的发展以及私营製造商用于研究工作的资金不断增加将推动该市场的发展。

基于挤压的生物列印是一种强大的三维 (3D) 生物列印技术，为器官製造提供了独特的机会。这项技术在过去十年中发展迅速。基于挤出的生物列印在列印各种生物化合物或设备方面提供了巨大的多功能性，包括细胞、组织、类器官和微流体设备，可应用于基础研究、药剂学、药物测试、移植和临床用途。基于挤出的生物列印为列印各种生物墨水提供了极大的灵活性，包括组织球体、细胞沉淀、微载体、去细胞基质成分和载有细胞的水凝胶。

例如，2022 年 4 月，芬兰生物列印新创公司 Brinter 宣布为其生物印表机推出一款新型挤出型 Visco Bio 医用列印头。与 Puredyne 密切合作推出的新型模组化列印头向市场提供创新技术，可将昂贵的医疗级材料的浪费降至最低。

市场地域占有率

北美约占全球生物列印器官移植市场份额的42.5%

预计北美地区将在预测期内占据最大的市场份额。该地区对器官移植的需求不断增长以及技术进步有助于推动市场发展。

例如，根据hrsa.gov发表的文章，2024年1月，死亡器官捐赠者超过16,000人，创年度新纪录，延续了13年的年度纪录趋势。进行了超过 46,000 例器官移植，继续保持每年创纪录的趋势。超过 10,000 名移植接受者是黑人和非西班牙裔。首次实施肝臟移植手术超过1万例。首次实施肺移植3000余例。肾臟和心臟移植也创下了新的年度记录。

例如，2023年11月，Cellink和Ossiform建立了策略伙伴关係，联手将基于Ossiform现有生物材料的可列印生物墨水商业化。该资料将于 2024 年开始销售，并将透过 Cellink 的商业管道独家分销。 Cellink 和 Ossiform 计画利用协同效应，向市场推出一种用于骨骼研究的高功能生物墨水。此次合作也涉及其他材料，包括临床级生物墨水。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 器官移植的需求不断增加
      • 技术进步
      • 研究工作拨出巨额资金
    • 限制
      • 人工器官成本高
      • 缺乏熟练的专业人员
      • 严格的监管要求
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 未满足的需求
  • PESTEL分析
  • 专利分析
  • SWOT分析

第 6 章：按流程

  • 喷墨生物列印
  • 雷射辅助生物列印
  • 基于挤出的生物列印
  • 声音生物打印
  • 磁性生物列印
  • 基于光聚合的生物列印
  • 其他的

第 7 章：Bioink 提供

  • 聚乙二醇二丙烯酸酯
  • 奈米纤维素
  • 胶原蛋白I
  • 石墨烯
  • 其他的

第 8 章：按使用的电池类型

  • iPS细胞
  • 间质干细胞
  • 角质形成细胞
  • 神经干细胞
  • 其他的

第 9 章：最终用户

  • 医院
  • 研究和教育机构
  • 专科诊所
  • 器官移植中心
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • 3D Systems Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Cell Ink
  • Materialise
  • Stratasys
  • General Electric Company
  • Desktop Metal Inc.
  • Aspect Biosystems Ltd.
  • EnvisionTEC Llc.
  • Ibio Inc.
  • Printivo (*LIST NOT EXHAUSTIVE)

第 13 章：附录

简介目录
Product Code: MD8607

Report Overview

The Global Bioprinting on Organ Transplant Market reached US$ 1.05 billion in 2023 and is expected to reach US$ 2.73 billion by 2031, growing at a CAGR of 13.2% during the forecast period 2024-2031.

Biomanufacturing of organs/tissues in vitro has been driven by two needs, i.e., organ transplantation and accurate tissue models. Bioprinting, also known as three-dimensional (3D) printing, is a technique used to develop many tissues/organs, such as the liver, skin, and heart. This technique is associated with printing structures using biomaterials, viable cells, and biomolecules. The creation of bioartificial organs has opened new avenues for future organ transplantation programs.

The demand for organ transplants has increased rapidly worldwide. Organ transplants are required due to the increased incidence of vital organ failure and the higher success rate of post-transplant outcomes. Globally, a major organ shortage crisis has emerged due to higher demand and insufficient supply of organs for transplant. 3D bioprinting uses cells or other bio-materials as printing inks to print complex 3D biological structures with biological functions according to the requirements of the bionic morphology, biological function, and cellular microenvironment through additive manufacturing methods.

Market Dynamics: Drivers

Increasing need for organ transplantation

The demand for global bioprinting on organ transplantation market is driven by multiple factors. The increase in the need for artificial organs and organ transplantation propels the market growth.

Furthermore, the demand for global bioprinting on organ transplantation market will be fueled by technological developments and funding allotted for research work. For instance, according to transplant.hrsa.gov, There were 46,632 organ transplants performed from both living and deceased donors in 2023. This represents an 8.7 percent increase over 2022 and a 12.7 percent increase over 2021, which was the first year with more than 40,000 organ transplants. There were 39,679 organ transplants from deceased donors. This represents an 8.9 percent increase over 2022 and marks the eleventh consecutive record-setting year.

For instance, according to an article posted by nih.gov in February 2024, India sees 17,000-18,000 solid organ transplants performed every year, the most in the world after the US and China, but remains behind several high-income countries in transplantation rates per million population (0.65). There has been progress in this area, such as an improvement in the harvesting of organs from deceased donors, with the average number of organ transplants per donor increasing from 2.43 in 2016 to 3.05 in 2022.

Restraints

Factors such as side effects and risks related to organ transplantation, the high cost of artificial organs, the shortage of skilled professionals, and stringent regulatory requirements for the approval of new techniques are expected to hamper the market.

Market Segment Analysis

The global bioprinting on organ transplantation market is segmented based on process, bioink, cell type used, end-user, and region.

The segment extrusion-based bioprinting accounted for approximately 47.8% of the global bioprinting on organ transplantation market share

The extrusion-based bioprinting segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and rising funds for private manufacturers for research work would drive this market.

Extrusion-based bioprinting is a powerful three-dimensional (3D) bioprinting technology that provides unique opportunities for use in organ fabrication. This technology has grown rapidly during the last decade. Extrusion-based bioprinting provides great versatility in printing various biological compounds or devices, including cells, tissues, organoids, and microfluidic devices that can be applied in basic research, pharmaceutics, drug testing, transplantation, and clinical uses. Extrusion-based bioprinting offers great flexibility in printing a wide range of bioinks, including tissue spheroids, cell pellets, microcarriers, decellularized matrix components, and cell-laden hydrogels.

For instance, in April 2022, Finland-based bioprinting startup Brinter announced the launch of a new extrusion-based Visco Bio medical printhead for its bioprinters. New modular printheads introduced in close collaboration with Puredyne, who provides innovative technologies to the market, allow waste of expensive medical grade materials to be kept to a minimum.

Market Geographical Share

North America accounted for approximately 42.5% of the global bioprinting on organ transplantation market share

North America region is expected to hold the largest market share over the forecast period. The increasing demand for organ transplantation, and technological advancements, in this region, help to propel the market.

For instance, according to an article published by hrsa.gov, in January 2024, More than 16,000 deceased organ donors, a new annual record and a continuation of a 13-year annual record trend. More than 46,000 organ transplants were performed, continuing an annual record-setting trend. More than 10,000 transplant recipients were Black, and non-Hispanic. More than 10,000 liver transplants were performed for the first time. More than 3,000 lung transplants were performed for the first time. New annual records are also set for kidney and heart transplants.

For instance, in November 2023, Cellink and Ossiform entered a strategic partnership to join forces to commercialize a ready-to-print bioink based on Ossiform's existing biomaterial. Sales of the material will begin in 2024 and will be distributed co-exclusively through Cellink's commercial channels. Cellink and Ossiform are planning to capitalize on synergies and bring to the market a highly functional bio-ink for bone-based research. The partnership has scope for additional materials, including clinical-grade bioinks.

Market Segmentation

By Process

  • Inkjet Bioprinting
  • Laser-Assisted Bioprinting
  • Extrusion-Based Bioprinting
  • Acoustic Bioprinting
  • Magnetic Bioprinting
  • Vatphotopolymerization-based bioprinting
  • Others

By Bioink

  • PEG diacrylate
  • Nanocellulose
  • Collagen I
  • Graphene
  • Others

By Cell Type Used

  • iPS Cells
  • Mesenchymal Stem Cells
  • Keratinocytes
  • Neural Stem Cell
  • Others

By End-User

  • Hospitals
  • Research and Educational Institutions
  • Specialty Clinics
  • Organ Transplantation Centers
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Market Competitive Landscape

The major global players in the global bioprinting on organ transplantation market include 3D Systems Corporation, Protolabs, Materialise, Stratasys, General Electric Company, Desktop Metal Inc., Aspect Biosystems Ltd., EnvisionTEC Llc., Ibio Inc., and Printivo among others.

Key Developments

  • In September 2022, 3D Systems announced the formation of a new, wholly-owned company called Systemic Bio(TM), a biotech company focused on the application of advanced bioprinting technologies to pharmaceutical drug discovery and development. Systemic Bio will leverage 3D Systems' breakthrough, production-level bioprinting technology to create extremely precise vascularized organ models using biomaterials and human cells.
  • In October 2023, Carcinotech and 3D bioprinting firm CELLINK announced a partnership to accelerate cancer drug development with 3D bio-printed tumor models. The partnership will focus on the development and commercialization of cutting-edge protocols for the biofabrication of 3D bio-printed tumor models using cancer cell lines. These models are designed to significantly improve accuracy and speed up drug development processes, ultimately reducing development costs and enhancing research output. The protocols will be made available for use on CELLINK's state-of-the-art BIO CELLX system.
  • In June 2022, CollPlant a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced the initiation of a study in large animals for its 3D bioprinted regenerative breast implant program, addressing the $2.8 billion global breast implant market.

Why Purchase the Report?

To visualize the global bioprinting on organ transplantation market segmentation based on, process, bioink, cell type used, end-user, and region, as well as understand key commercial assets and players.

  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of global bioprinting on organ transplantation market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in Excel consisting of key products of all the major players.

The global bioprinting on organ transplantation market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Process
  • 3.2. Snippet by Bioink
  • 3.3. Snippet by Cell Type Used
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Need for Organ Transplantation
      • 4.1.1.2. Technological Advancements
      • 4.1.1.3. Hefty Funds Allotted for the Research Work
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Artificial Organs
      • 4.1.2.2. Shortage of Skilled Professionals
      • 4.1.2.3. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. By Process

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 6.1.2. Market Attractiveness Index, By Process
  • 6.2. Inkjet Bioprinting*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Laser-Assisted Bioprinting
  • 6.4. Extrusion-Based Bioprinting
  • 6.5. Acoustic Bioprinting
  • 6.6. Magnetic Bioprinting
  • 6.7. Vatphotopolymerization-based Bioprinting
  • 6.8. Others

7. By Bioink

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
    • 7.1.2. Market Attractiveness Index, By Bioink
  • 7.2. PEG Diacrylate*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Nanocellulose
  • 7.4. Collagen I
  • 7.5. Graphene
  • 7.6. Others

8. By Cell Type Used

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
    • 8.1.2. Market Attractiveness Index, By Cell Type Used
  • 8.2. iPS Cells*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Mesenchymal Stem Cells
  • 8.4. Keratinocytes
  • 8.5. Neural Stem Cells
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Research and Educational Institutions
  • 9.4. Speciality Clinics
  • 9.5. Organ Transplantation Centers
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. UK
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. 3D Systems Corporation *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Cell Ink
  • 12.3. Materialise
  • 12.4. Stratasys
  • 12.5. General Electric Company
  • 12.6. Desktop Metal Inc.
  • 12.7. Aspect Biosystems Ltd.
  • 12.8. EnvisionTEC Llc.
  • 12.9. Ibio Inc.
  • 12.10. Printivo (*LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us